Barry Brand


CeNeRx, expecting trial results and drug partner in 2012, raises $4.8M

Central nervous system drug development company CeNeRx BioPharma is developing an antidepressant whose novel mechanism causes fewer side effects, and the company is now in active talks with large pharmaceutical companies who could take the candidate, called TriRima, into phase 3 studies. “We’re looking forward to (trial) results and a deal in 2012,” said CeNeRx […]